Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic investigation of non-affective psychosis and depression as causal risk factors for dementia.

BMJ mental health·2026
Same author

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Nature genetics·2026
Same author

Identification of common variants influencing risk of the three-repeat tauopathy Pick's disease: a genome wide association study.

medRxiv : the preprint server for health sciences·2026
Same author

Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale.

Science advances·2025
Same author

Machine learning in Alzheimer's disease genetics.

Nature communications·2025
Same author

MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Jun 12, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K

Decoding the genomic symphony: unravelling brain disorders through data integration and machine learning.

Matthew Bracher-Smith1, Valentina Escott-Price2,3

  • 1UK Dementia Research Institute at Cardiff, Cardiff University, Cardiff, UK.

Molecular Psychiatry
|November 2, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) is revolutionizing brain disorder research by enhancing genetic prediction and patient stratification. This approach offers a roadmap for decoding complex genomic patterns and improving disease risk assessment.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K
Decoding Natural Behavior from Neuroethological Embedding
08:00

Decoding Natural Behavior from Neuroethological Embedding

Published on: October 3, 2025

541

Related Experiment Videos

Last Updated: Jun 12, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K
Decoding Natural Behavior from Neuroethological Embedding
08:00

Decoding Natural Behavior from Neuroethological Embedding

Published on: October 3, 2025

541

Area of Science:

  • Neurogenetics
  • Computational Biology
  • Genomic Medicine

Background:

  • Brain disorders possess complex genetic architectures that are challenging to decode using traditional methods.
  • Machine learning (ML) offers advanced computational approaches for analyzing large-scale genetic and phenotypic data.

Purpose of the Study:

  • To review the strengths and limitations of ML methods in the context of brain disorder genetics.
  • To highlight ML applications in genetic prediction, patient stratification, and modeling genetic interactions.
  • To provide a roadmap for leveraging ML to unravel genomic complexity in brain disorders.

Main Methods:

  • Review of ML techniques including their application in augmenting polygenic risk scores (PRS).
  • Integration of functional genomics and multimodal data.
  • Incorporation of biological knowledge into ML models for enhanced interpretability.

Main Results:

  • ML methods show promise in improving genetic prediction and patient stratification for brain disorders.
  • Advanced ML techniques can address challenges posed by rare variants and weak genetic effects.
  • ML is expected to surpass classical statistical methods in disease risk prediction and subgroup identification.

Conclusions:

  • ML is a powerful tool for decoding the genetic complexity of brain disorders.
  • Integrating diverse data types and biological knowledge enhances ML model performance and interpretability.
  • ML advancements, including federated learning, are poised to drive significant discoveries in neurogenetics.